Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Forecast to Reach $2.27 Billion by 2030 at 23% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Over The 2026–2030 Period?
The market size for artificial intelligence (AI) tele-oncology radiation dose schedulers has seen significant expansion in recent years. This market is projected to increase from $0.81 billion in 2025 to $0.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.3%. The growth observed historically stems from various factors, including a heightened requirement for remote cancer treatment planning, the increasing acceptance of tele-oncology platforms, a rising call for precise radiation dose calculation, the expanded utilization of AI in oncology decision support, the global escalation in cancer occurrence, the ongoing digital evolution within hospitals, the greater deployment of cloud-based medical systems, a growing need for workflow automation in radiotherapy, an intensified focus on reducing treatment inaccuracies, and the broader integration of intelligent oncology scheduling tools.
The artificial intelligence (AI) tele-oncology radiation dose scheduler market size is anticipated to undergo significant expansion in the coming years, reaching $2.28 billion by 2030, at a compound annual growth rate (CAGR) of 23.0%. This projected growth during the forecast period is driven by factors such as the broadening of tele-oncology networks, the adoption of AI-enabled treatment planning platforms, an increasing need for automated dose calculation systems, the uptake of cloud-based oncology scheduling modules, the deployment of predictive oncology algorithms, the development of remote radiotherapy review tools, the demand for precision-based cancer care, the integration of AI tools within oncology departments, strategic partnerships between AI vendors and cancer centers, and the growing acceptance of tele-radiation workflows. Prominent trends for the forecast period include advancements in AI-driven radiotherapy dose prediction, enhancements in cloud-based oncology scheduling platforms, progress in real-time dose optimization engines, innovations in automated treatment planning systems, new developments in predictive oncology algorithms, breakthroughs in virtual radiation oncology workflows, the merging of tele-oncology with hospital information systems, the integration of AI dose schedulers with imaging platforms, the incorporation of remote dose-review tools for oncologists, and the establishment of multi-center tele-radiation networks.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30520&type=smp
What Drivers Are Expected To Influence The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market During The Forecast Period?
The artificial intelligence (AI) tele-oncology radiation dose scheduler market is expected to expand in the future, driven by the increasing incidence of cancer. Cancer, a condition characterized by the uncontrolled proliferation and spread of abnormal cells, can damage surrounding tissues and organs if not effectively managed. The growing prevalence of cancer is linked to lifestyle-related risk factors such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, which elevate the likelihood of developing various cancers. Artificial intelligence (AI) tele-oncology radiation dose schedulers support cancer management by optimizing and personalizing radiation treatment plans through remote, data-driven analysis, thereby enhancing patient outcomes by ensuring accurate dosing, reducing treatment delays, and facilitating consistent care across locations. For example, NHS Digital, a UK government organization, reported in October 2025 that England recorded 354,820 new cancer diagnoses in 2023, averaging 972 diagnoses daily, representing an increase of 8,605 cases compared to 2022; prostate cancer was the most frequently diagnosed at 58,137 new cases, marking a 6% rise in registrations from the previous year. Thus, the rising prevalence of cancer is a primary driver for the growth of the artificial intelligence (AI) tele-oncology radiation dose scheduler market.
How Is The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Segmented Across Key Categories?
The artificial intelligence (AI) tele-oncology radiation dose scheduler market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning Algorithms, Natural Language Processing, Computer Vision, Predictive Analytics
3) By Deployment Mode: On-Premise (Local Installation), Cloud-Based (SaaS), Hybrid Deployment
4) By Application: Auto-Contouring And Segmentation (OAR Or Target), Treatment Plan Generation And Optimization, Dose Prediction And Quality Assurance (QA), Workflow And Resource Scheduling Optimization, Adaptive Radiotherapy Planning
5) By End-User: Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users
Subsegments:
1) By Software: Analytics And Reporting Software, Recommendation Engine Software, Natural Language Processing Software, Machine Learning Model Management Tools, Computer Vision Software, Integration And API Management Software, Mobile And Web Application Software
2) By Hardware: AI-Optimized Servers, Edge Computing Devices, Sensors And IoT Devices, Smart Cameras, GPUs And AI Accelerators, Storage Systems, Networking And Connectivity Hardware
3) By Services: Consulting Services, Implementation And Integration Services, Training And Support Services, Managed AI Services, Maintenance And Upgradation Services, Custom AI Development Services, Data Management And Annotation Services
Which Upcoming Trends Are Expected To Influence The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market?
Leading companies in the AI tele-oncology and radiation therapy market are prioritizing the development of advanced solutions, such as AI-powered dose prediction, to forecast personalized radiation dose distributions and thereby enhance the efficiency of treatment planning. These AI-powered dose prediction platforms are software solutions designed to analyze imaging and anatomical data, generate clinically achievable 3D dose distributions, and support timely adjustments for optimizing therapy. For instance, in March 2025, MVision AI, a health-tech company based in Finland, unveiled Dose+. This particular AI-powered dose prediction platform incorporates specialized models for prostate and pelvic lymph node cases, customizes dose distributions to each patient’s anatomy, and supports integration with standard treatment planning systems via DICOM to facilitate efficient planning workflows. This launch signifies a considerable technological stride by integrating AI-driven dose prediction into routine clinical practice, connecting traditional planning with automated, patient-specific optimization, and equipping clinicians with a scalable, efficient solution for precise, personalized radiation therapy.
Who Are The Dominant Players Shaping The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Landscape?
Major companies operating in the artificial intelligence (AI) tele-oncology radiation dose scheduler market are IBM Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Varian Medical Systems Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.
Read the full artificial intelligence (ai) tele-oncology radiation dose scheduler market report here:
Which Region Is Anticipated To See The Fastest Growth In The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market?
North America was the largest region in the AI tele-oncology radiation dose scheduler market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) tele-oncology radiation dose scheduler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30520&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market 2026, By The Business Research Company
Artificial Intelligence In Oncology Market Report 2026
Radiation Dose Management Market Report 2026
https://www.thebusinessresearchcompany.com/report/radiation-dose-management-global-market-report
artificial intelligence ai radiology tool global market report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
